MRI shows selective psoas and rectus atrophy with reduced trunk strength in chronic low back pain, suggesting functional imbalance.

Back pain is often dismissed as temporary discomfort caused by poor posture, strenuous activities or aging. However, when left untreated, persistent back pain can be a warning sign of underlying ...

Researchers have identified a bone-driven signaling pathway that may explain how spinal degeneration leads to chronic pain.

It’s a real pain in the back. An estimated 80% of Americans will experience back pain at some point in their lives — and for around 16 million of those adults, the issue is chronic and with no easy ...

Jalna resident Shri Shyam Mudhokar Kulkarni found lasting relief from three years of chronic low back pain at Patanjali ...

Here’s some spine-tingling news. New research suggests a drug already available on pharmacy shelves could help ease chronic lower back pain. It’s a welcome discovery for the millions of Americans who ...

For anyone who has ever felt paralyzed with chronic low back pain, it won’t be surprising that back pain is the leading cause of disability: What may be surprising is the best way to treat it. “We ...

A clinical trial at Brown University Health to treat chronic low back pain with a one-time, non-surgical injection treatment is seeking to enroll patients in Rhode Island.

Forbes contributors publish independent expert analyses and insights. Diane Omdahl is a Medicare expert who keeps her readers in the know. My back hurts so bad I can’t straighten up. My back pain is ...

AppliedVR continues to build out clinical evidence to support the use of immersive therapeutics to address chronic pain. The company's flagship virtual reality device for chronic lower back pain ...

In a new study, older adults who received acupuncture had less pain and better mobility than those who got medication or physical therapy. A new clinical trial in older adults finds that acupuncture ...

Most nonsurgical and noninterventional treatments for low back pain failed to outperform placebo in a new systematic review and meta-analysis, with just 10% showing only modest pain relief.